SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-067779
Filing Date
2024-06-03
Accepted
2024-06-03 16:08:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2416229d1_defa14a.htm DEFA14A 92426
2 GRAPHIC image_001.jpg GRAPHIC 3923
3 GRAPHIC tm2416229d1_defa14aimg02.jpg GRAPHIC 391537
4 GRAPHIC tm2416229d1_defa14aimg03.jpg GRAPHIC 221595
  Complete submission text file 0001104659-24-067779.txt   943933
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35963 | Film No.: 241013663
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)